Also back in June 2014 the FDA added a label change requirement to testosterone products covering potential venous blood clots: http://www.fda.gov/Drugs/DrugSafety/ucm401746.htm
At the time I chatted with a senior intensive care doctor (ie. knows a lot about old people) about it. She advised that it made no difference because any decent doctor already knows that testosterone increases red blood cell count thereby thickening the blood. Doctors would already be taking into account this when prescribing testosterone.
Same should also apply to the latest labelling requirement. A doctor should already be across all the pros and cons before prescribing the stuff. Any doctor worth their salt that it is. And, speaking of salt, doesn't that potentially increase chance of stroke. Where's the warning label?!?
- Forums
- ASX - By Stock
- TP dropped to $0.58
Also back in June 2014 the FDA added a label change requirement...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 60019 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 225945 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 60019 | 0.054 |
3 | 250339 | 0.053 |
1 | 20000 | 0.052 |
1 | 10000 | 0.051 |
4 | 247490 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 225945 | 1 |
0.060 | 115000 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
0.063 | 111500 | 2 |
Last trade - 16.12pm 18/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable